During the past decade, Mount Sinai Medical Center Heart Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Medical Center Heart Institute" are "Coronary Artery Disease" (1 trials) and "Peripheral Arterial Occlusive Disease" (1 trials). Many other conditions were trialed in "Mount Sinai Medical Center Heart Institute" in a lesser frequency.

Most popular intervention types in "Mount Sinai Medical Center Heart Institute" are "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PAD endovascular treatments" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Medical Center Heart Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mount Sinai Medical Center Heart Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mount Sinai Medical Center Heart Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Medical Center Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".